Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand.

BACKGROUND Population-based estimates of the incidence of invasive pneumococcal disease are unavailable for Thailand and other countries in Southeast Asia. We estimated the incidence of pneumococcal bacteremia cases requiring hospitalization in rural Thailand. METHODS Blood cultures were performed on samples from hospitalized patients in 2 rural provinces where active, population-based surveillance of community-acquired pneumonia is conducted. Blood cultures were performed at clinician discretion and were encouraged for all patients with suspected pneumonia and all children aged <5 years with suspected sepsis. Pneumococcal antigen testing was performed on positive blood culture specimens that failed to grow organisms on subculture. RESULTS From May 2005 through June 2007, 23,853 blood culture specimens were collected overall, and 7319 were collected from children aged <5 years, which represented 66% and 47% of target patients, respectively. A total of 72 culture-confirmed pneumococcal bacteremia cases requiring hospitalization were identified. An additional 44 patients had media from positive blood cultures that yielded no growth on subculture but that had positive results of pneumococcal antigen testing. Of the 116 confirmed cases of bacteremia, 27 (23%) occurred in children aged <5 years; of these, 9 (33%) were confirmed by antigen testing only. The incidence of pneumococcal bacteremia cases requiring hospitalization among children aged <5 years had a range of 10.6-28.9 cases per 100,000 persons (incidence range if cases detected by antigen are excluded, 7.5-14.0 cases per 100,000 persons). CONCLUSIONS Invasive pneumococcal disease is more common than was previously suspected in Thailand, even on the basis of estimates limited to hospitalized cases of bacteremia. These estimates, which are close to estimates of the incidence of hospitalized cases of pneumococcal bacteremia in the United States before introduction of pneumococcal conjugate vaccine, provide important data to guide public health care policy and to inform discussions about vaccine introduction in Thailand and the rest of Southeast Asia.

[1]  D. Inwald,et al.  Invasive pneumococcal disease , 2011, Archives of Disease in Childhood: Education & Practice Edition.

[2]  S. Azin.  AN OVERVIEW ON THE 2008 UNAIDS REPORT ON THE GLOBAL AIDS EPIDEMIC , 2010 .

[3]  T. Cherian,et al.  Standardizing surveillance of pneumococcal disease. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  L. Hammitt,et al.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. , 2007, JAMA.

[5]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  K. Chokephaibulkit,et al.  Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000-2005. , 2007, Vaccine.

[7]  David Coleman,et al.  INVASIVE PNEUMOCOCCAL DISEASE IN AUSTRALIA , 2007 .

[8]  Des Anticorps.  Weekly Epidemiological Record Relevé Épidémiologique Hebdomadaire World Health Organization Geneva Organisation Mondiale De La Santé Genève Summary and Conclusions , 2022 .

[9]  P. Newton,et al.  Causes of community-acquired bacteremia and patterns of antimicrobial resistance in Vientiane, Laos. , 2006, The American journal of tropical medicine and hygiene.

[10]  S. Dowell,et al.  The incidence of pneumonia in rural Thailand☆ , 2006, International Journal of Infectious Diseases.

[11]  R. Gertz,et al.  Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. , 2006, Journal of clinical microbiology.

[12]  C. Whitney,et al.  Cost-Effectiveness of Pneumococcal Conjugate Vaccine: Evidence From the First 5 Years of Use in the United States Incorporating Herd Effects , 2006, The Pediatric infectious disease journal.

[13]  W. Schaffner,et al.  Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. , 2006, The New England journal of medicine.

[14]  S. Dowell,et al.  DIAGNOSTIC VALUE OF SERUM PROCALCITONIN AND C-REACTIVE PROTEIN IN EGYPTIAN CHILDREN WITH STREPTOCOCCAL TONSILLOPHARYNGITIS , 2006, The Pediatric infectious disease journal.

[15]  Clinical,et al.  Performance standards for antimicrobial disk susceptibility tests : approved standard , 2006 .

[16]  R. Pebody,et al.  Pneumococcal disease surveillance in Europe. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[17]  Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015. , 2006, MMWR. Morbidity and mortality weekly report.

[18]  N. Akar,et al.  PCR evaluation of false-positive signals from two automated blood-culture systems. , 2006, Journal of medical microbiology.

[19]  A. Schuchat,et al.  Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. , 2005, Vaccine.

[20]  S. Madhi,et al.  The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  C. Woods,et al.  Streptococcus pneumoniae Antigen Test Using Positive Blood Culture Bottles as an Alternative Method To Diagnose Pneumococcal Bacteremia , 2005, Journal of Clinical Microbiology.

[22]  A. Lloyd,et al.  Pneumococcal pneumonia in the UK--how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV). , 2005, Vaccine.

[23]  K. Ko,et al.  High Prevalence of Antimicrobial Resistance among Clinical Streptococcus pneumoniae Isolates in Asia (an ANSORP Study) , 2004, Antimicrobial Agents and Chemotherapy.

[24]  Steven Black,et al.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The Journal of pediatrics.

[25]  Mindy J. Perilla,et al.  Manual for the laboratory identification and antimicrobial susceptibility testing of bacterial pathogens of public health importance in the developing world. Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Neisseria gonorrhoeae Salmonella serotype Typhi Shigella and Vibrio cho , 2003 .

[26]  V. Krause,et al.  Invasive pneumococcal disease in Australia, 2001. , 2002, Communicable diseases intelligence quarterly report.

[27]  A. Schuchat,et al.  Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. , 2001, JAMA.

[28]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[29]  J. Henrichsen,et al.  Typing of Streptococcus pneumoniae: past, present, and future. , 1999, The American journal of medicine.

[30]  P. Martus,et al.  Controlled Clinical Laboratory Comparison of Two Supplemented Aerobic and Anaerobic Media Used in Automated Blood Culture Systems To Detect Bloodstream Infections , 1998, Journal of Clinical Microbiology.

[31]  F. Tenover,et al.  Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae , 1996, Journal of clinical microbiology.

[32]  J. Henrichsen,et al.  Six newly recognized types of Streptococcus pneumoniae , 1995, Journal of clinical microbiology.

[33]  J. Robbins,et al.  Production of monovalent antisera by induction of immunological tolerance for capsular typing of Streptococcus pneumoniae. , 1992, FEMS microbiology letters.

[34]  E. Lund.  Laboratory diagnosis of Pneumococcus infections. , 1960, Bulletin of the World Health Organization.

[35]  A. White,et al.  In this Supplement , 1935, American Journal of International Law.